• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

African-American cancer patients more likely to receive risky analgesics

byMonica ParksandMarc Succi, MD
July 26, 2014
in Chronic Disease, Oncology, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. African-American cancer patients with chronic kidney disease were more likely to receive morphine over oxycodone when compared to white patients.                                                          

Evidence Rating Level: 2 (Good) 

Study Rundown: Renal impairment is common among cancer patients, particularly African Americans, who are more likely to have comorbid diabetes or hypertension. As a result, providers must carefully consider whether to prescribe opioids with renally-cleared toxic metabolites for pain control in these patients. However, previous studies have suggested that these patients are at a higher risk for opioid treatment disparities compared to other treatment modalities. The purpose of this study was to evaluate the relationship between race versus insurance type on opioid prescription patterns in the setting of renal impairment.

At the conclusion of this study, the authors found that race was a strong predictor of the type of opioid prescribed even after controlling for insurance type. Furthermore, race was a significant independent predictor for severity of analgesia adverse effect, in addition to type of opioid. Based on these findings, the authors suggested that these patients are particularly vulnerable to variability in opioid prescribing practices, possible biases, and lack of knowledge of toxic metabolites. It should be noted that this was a small study that did not stratify by medication release forms or account for additional analgesics that may have been prescribed.

Click to read the study in JCO

In-Depth [retrospective cohort]: This study was a retrospective analysis of a prospective cohort study on analgesia for cancer pain. 182 patients diagnosed with solid tumors or multiple myeloma with cancer-related pain requiring opioids were included. The study authors limited inclusion of schedule II opioids to morphine and oxycodone. Outcomes measured included prescription of morphine or oxycodone, presence of impaired GFR, analgesic adverse effects, pain, and health insurance information. African-American patients had 79% lower odds of having private insurance compared to white patients (odds ratio, 0.21; 95% CI, 0.12 to 0.37; p < .001), but after controlling for insurance, these patients were significantly less likely to be prescribed morphine than oxycodone (p < 0.0007). Among patients with CKD, there was still a significant relationship between race and the type of opioid prescribed (odds ratio, 0.21; 95% CI 0.06-0.72; p < 0.012). Race was also associated with severity of analgesic adverse effects (p = 0.015), while the type of opioid prescribed predicted adverse effect severity after adjusting for race (p = 0.037). Race no longer predicted adverse effect severity after adjusting for type of opioid (p = 0.085).

More from this author: Rituximab linked with reduced chronic immune disease following stem cell transplantation, High-dose prophylaxis for hemophilia increases costs with minimal benefit, Ambrisentan found ineffective against idiopathic pulmonary fibrosis 

RELATED REPORTS

Radiofrequency thermal ablation superior to percutaneous ethanol injection in hepatocellular carcinoma [Classics Series]

Arterial chemoembolization improves survival in non-resectable hepatocellular carcinoma [Classics Series]

Unsweetened coffee consumption is associated with reduced risk of mortality

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: african-americancancerpain medication
Previous Post

No increased overall risk of systemic events with use of anti-VEGF eye treatments

Next Post

Pain and itch associated with histologic features of skin cancers

RelatedReports

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Hematology/Oncology Classics

Radiofrequency thermal ablation superior to percutaneous ethanol injection in hepatocellular carcinoma [Classics Series]

June 30, 2022
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
Hematology/Oncology Classics

Arterial chemoembolization improves survival in non-resectable hepatocellular carcinoma [Classics Series]

June 29, 2022
European data showed coffee consumption associated with lower mortality
Cardiology

Unsweetened coffee consumption is associated with reduced risk of mortality

June 21, 2022
#VisualAbstract Ponatinib with FLAG-IDA is a feasible and active treatment strategy in patients with blast-phase chronic myeloid leukaemia
StudyGraphics

#VisualAbstract Ponatinib with FLAG-IDA is a feasible and active treatment strategy in patients with blast-phase chronic myeloid leukaemia

June 12, 2022
Next Post
Video-based behavioral intervention benefits clinical skin examinations

Pain and itch associated with histologic features of skin cancers

Patient centeredness poor predictor of fertility care dropout

Oocyte vitrification not associated with adverse obstetric or perinatal outcomes

Shorter surveillance follow-up for stage I seminoma may be sufficient

Shorter surveillance follow-up for stage I seminoma may be sufficient

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Relugolix combination therapy is efficacious for endometriosis-associated pain
  • Age-based products and longer interdose intervals may reduce the risk of cardiac disease following COVID-19 mRNA vaccination
  • OPTN and UNOS update policy regarding hepatocellular carcinoma [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.